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Objective: To probe into the influence of changes of ovarian hormones on the pathogenesis of the specific 
sub-type premenstrual syndrome (PMS) and reveal partial microcosmic mechanisms of adverse flow of 
liver-qi. Methods: Estradiol (E2) and progesterone (P) levels in serum were determined at different phases of 
menstrual cycle by radioimmunoassay. Results: In the group of PMS with adverse flow of liver-qi, the 
secretive peak value of E2 and P at the follicular phase significantly decreased, and the secretive peak value at 
the luteal phase did not come into being. Conclusions: Low E2 and P secretive peak at the follicular phase 
and absence of secretive peak at the luteal phase is one of the microcosmic mechanisms of PMS with adverse 
flow of liver-qi. One of the pathophysiologic mechanisms of specific sub-type PMS is probably the 
continuous low level of E2 and P.  
 
Premenstrual syndrome (PMS) refers to the 
syndrome occurring repeatedly before the menstrual 
period, which affects women’s daily life and work, 
including mental states, and changes in the body and 
behavior. 1 In the epidemiological researches on the 
distribution law of syndrome patterns of this 
syndrome, we have found that among the types of 
PMS, adverse flow of liver-qi covers 58.9%, being 
the main type of the syndrome2. There are relevant 
reports saying that PMS patients tend to have higher 
or relatively higher level of Estradiol (E2), and lower 
level of P progesterone (P). There are also reports 
supporting opposite results. We think that two things 
should be emphasized in studying effects of exact of 
E2 and P levels on pathogenesis of PMS: one being 
the TCM sub-type of PMS, the other being the 
dynamic changes of these two sexual hormones in the 
menstrual cycle. So, we have selected PMS patients 
with adverse flow of liver-qi, and observed the 
dynamic changes of E2 and P levels at different 
phases of menstrual cycle.  
CLINICAL DATA 
The research objects 
The 726 research objects were all women of 
childbearing age from The Second Qingdao Rubber 
Factory, Qingdao No. 45 Middle School, Jinan 
Second State Cotton Mill, and Jinan Polytechnic 
School of First Business, ranging in age from 23–40 
years, with a mean of 34.3±0.6 years. The 
epidemiologic investigations were carried out in the 
above-mentioned units, and 69 cases up to the 
diagnostic standard of PMS with adverse flow of 
liver-qi were taken as the case group and 24 cases 
were selected randomly as the control group. These 
two groups had no significant statistical differences 
in age, occupation, and level of education (P>0.05), 
having comparability. The exclusions: women up to 
the diagnostic standard of PMS with adverse flow of 
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liver-qi but were receiving other treatments; women 
accompanied with other diseases; women below 18 
years or beyond 40 years old, who were in 
adolescence or in climacteric with menstrual disorder; 
those who were taking contraceptive drugs, and 
pregnancy or breast feeding women.  
Criteria for diagnosis 
Diagnostic criteria for PMS: Since there are no 
unified diagnostic criteria for this syndrome at 
present in our country, the criteria we used were 
determined according to Obstetrics and Gynecology.3 
Women having physical, mental and behavior 
abnormalities before the menstrual period with more 
than four symptoms, which disappeared 
spontaneously after the menstrual period, were 
diagnosed as having this syndrome.  
Diagnostic criteria for PMS with adverse flow of 
liver-qi: Adverse flow of liver-qi is a syndrome 
characterized by hyperactivity of liver-qi due to 
excessive liver-qi. The main symptoms: 1) 
premenstrual irritability and peevishness, and in 
severe cases, big anger with unknown reason; 2) 
breast distension; 3) headache. The secondary 
symptoms: 1) insomnia and dreamy sleep; 2) lower 
abdominal distention or pain; 3) epigastric distending 
pain, or nausea and vomiting; 4) inability to 
concentrate the mind, and decreased ability to work 
and do housework; and 5) advanced menstrual cycle. 
The tongue proper was light red with thin-white or 
yellow coating, and the pulse wiry. The diagnosis 
could be made if the patient had the main symptoms 
of 1) and 2) or of 1) and 3) plus two secondary 
symptoms.  
METHODS 
Sampling methods 
The fasting blood samples were taken at 8–10 in all 
cases under observation at 4-times per menstrual 
cycles, including the menstrual phase (1st-5th day), 
follicular phase (6th–14th day), luteal phase (15th – 
23rd day), and premenstrual phase (24th – 28th day). 
The blood samples were taken for two months in 
succession.  
Determination methods 
125I labeled E2 and P radioimmunoassay kit marked 
was provided by Shanghai Research Institute of 
Immunologic Reagent, and the FMJ automatic 
gamma radioimmunoassay counter was produced by 
Shang Li Instrument Factory of Shanghai Institute of 
Detection Technology. The blood samples were 
centrifuged at 3000 rpm for 20 minutes. After 
separation, each portion of serum was tested in two 
parallel tubes. E2 and P levels in serum were 
determined by radioimmunoassay according to the 
instruction. The average value of the two tubes was 
set as the test value.  
The statistical methods 
Student t test was performed for the comparison 
between the group of adverse flow of liver-qi and the 
normal group, and single factor analysis of variance 
for the comparison between the 4 different phases of 
menstrual cycle by applying SAS 8.1 statistical 
software.  
RESULTS 
Changes in the level of serum E2 before and after the 
attack in patients of PMS with adverse flow of 
liver-qi: The periodic changes in ovarian hormone of 
the normal control group showed normal signs i.e. 
the two secretive peak values of E2 at the follicular 
and luteal phase were normal; and analyzed by 
one-factor analysis of variance, the E2 levels at the 4 
phases showed significant differences (P<0.01). In 
the group of PMS with adverse flow of liver-qi, the 
secretive peak value at the follicular phase decreased 
significantly, and the secretive peak value at the 
luteal phase did not come into being, which, as 
compared with the normal control group, had very 
significant differences (P<0.01). The results indicated 
that patients in the group of PMS with adverse flow 
of liver-qi had disturbance in the normal periodic 
changes of female sex hormone in the menstrual 
cycle. The microcosmic changes with abnormal or 
absence of formation of secretive peak and decrease 
of female sex hormone tended to continuously exist 
before the menstrual period and after the menstrual 
period (Table 1). 
Changes in the level of serum P before and after the 
attack in patients of PMS with adverse flow of 
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liver-qi: The P level of the normal control group 
showed normal secretive peak value at the luteal 
phase, which had significant differences as compared 
with other phases (P<0.01). In the group of adverse 
flow of liver-qi, the secretive peak of P did not come 
into being at the luteal phase, which did not show 
significant differences as compared with the other 
phases (P>0.05). Besides, at the menstruation phase 
and follicular phase when P level should decrease, 
the group of adverse flow of liver-qi did not show the 
corresponding decrease (P>0.05). This suggested that 
patients with adverse flow of liver-qi had disturbance 
in the normal periodic changes of menstrual cycle, 
indicating dysfunction of corpus luteum (Table 2).  
Table 1. Serum E2 levels of PMS patients with adverse liver-qi at different menstrual phases (pg/ml, x ±s)  
Group n Follicular phase Luteal phase Premenstrual phase Menstrual phase 
Adverse liver-qi 69 117.15±10.23*  24.92±1.02* 5.16±0.85* 24.95±1.78* 
Normal control 24 278.41±30.05 240.25±10.17 85.10±7.63 12.15±0.64 
Note: Compared with the normal control group, *P < 0.01.   
Table 2. Serum P levels of PMS patients with adverse liver-qi at different menstrual phases (pg/ml, x ±s) 
Group n Follicular phase Luteal phase Premenstrual phase Menstrual phase 
Adverse liver-qi 69 3.72±0.15* 3.53±1.81* 4.38±1.07* 3.44±0.78* 
Normal control 24 2.30±0.40 28.14±2.36 6.25±1.59 0.91±0.03 
Note: Compared with the normal control group, *P < 0.01.   
DISCUSSION 
Modern research on PMS has proved that the attack 
is closely related with ovarian hormone. It is 
considered that higher or relatively higher level of 
serum E2 and lower level of serum P constitute the 
main causative factor. However, recent western 
researches do not support this idea, which hold that 
the level of ovarian hormone is within normal range.4 
Owing to the contradicted research results, the 
authors can infer that different symptoms may form 
different sub-types of PMS, among which some have 
higher level and some have lower level of ovarian 
hormone, resulting in normal limits of ovarian 
hormone level for PMS, and different diagnostic 
criteria and therapeutic methods for different 
sub-types.5 However, there are no reports on the 
specific diagnostic criteria, pathogenic mechanism 
and the functions of ovarian hormone in each 
sub-type PMS. The early epidemiological researches 
on PMS have proved that the distribution of 
syndrome patterns of PMS is quite regular, marked 
by dysfunction of the liver in governing normal flow 
of qi as the main manifestation, and the adverse flow 
of liver-qi as the main syndrome and stagnation of 
liver-qi as the secondary syndrome. The two 
syndromes have different clinical manifestations and 
pathogenic mechanisms. In referring to the 
international reports on the clinical manifestations of 
premenstrual dysphoric disorder (PMDD) of the 
sub-type PMS, the PMS with adverse flow of liver-qi 
is very similar to this sub-type. Therefore, PMS with 
adverse flow of liver-qi can be regarded as a very 
important sub-type of PMS.  
The authors selected patients of PMS with adverse 
flow of liver-qi, and conducted regular follow-up 
tests on the dynamic changes in ovarian hormone 
level at different phases of menstrual cycle. They 
found that the E2 level of PMS patients with adverse 
flow of liver-qi was not relatively higher but 
obviously lower. Compared with the secretive peak 
of E2 and P at early, middle and late phase of 
progesterone in normal women of childbearing age, 
PMS patients with adverse flow of liver-qi did not 
have the formation of secretive peak of E2 and P. 
Therefore, the absence of secretive peak of E2 and P 
can definitely affect normal ovulation. However, 
theoretically, it doesn’t mean that this absence of 
secretive peak of E2 and P can lead to absence of 
ovulation because normal ovulation is a very 
complicated feedback regulatory mechanism, in 
which hypophysis, hypothalamus, luteotropic 
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hormone (LH), and follicle-stimulating hormone 
(FSH) all play very important role, and simple 
absence of E2 and P without other changes doesn’t 
certainly cause stop of ovulation.  
Therefore, this result suggests that most of the PMS 
patients with adverse flow of liver-qi are likely to 
have dysfunction corpus luteum progesterone, and 
that the pathological changes of PMS patients with 
adverse flow of liver-qi exist before the appearance 
of manifestations of the syndrome, which accords 
with the results of the modern medical researches. It 
has been reported recently that the pathologic 
changes of this disease occur not only at the middle 
and late luteal phases, but also at the early or even 
earlier luteal phase. 5 This research has added new 
proofs to the modern medical knowledge of the 
sub-type PMS with adverse flow of liver-qi.  
Achievements of this research have deepened the 
knowledge about the new causative factor of latent 
stagnation of qi and blood that the authors put 
forward before. At that time, the authors tried to use 
TCM etiology to explain the phenomenon on PMS 
patients that they are usually quite healthy and 
generally do not have symptoms to differentiate, but 
periodically have attacks each month. Early in the 
1980s, there were already scholars who expounded 
and proved that qi and blood in TCM implicate 
endocrine hormone in western medicine. 6 Therefore, 
latent stagnation of qi and blood in TCM implicates 
latent disturbance of endocrine hormone. Owing to 
limited condition at that time, the essence of this 
concept was not explored completely. The results of 
this research have revealed part of the essence of the 
concept i. e. low level of E2 and P in the whole 
menstrual cycle may be the specific implication of 
latent stagnation of qi and blood. Putting forward and 
deepening of this concept suggests that the research 
on the etiology of the syndrome should transfer from 
the traditional macroscopic differentiation to the 
modern microscopic exploration, which is different 
from the above-mentioned report that the level of 
ovarian hormone of PMS patients is within the 
normal range. This research shows the levels of E2 
and P are significantly lower than normal, the main 
reason lies that the former failed to distinguish the 
symptoms of the sub-type PMS. The conclusion 
drawn by combining the syndromes of both Chinese 
and western medicine may be more truly reflect the 
specific pathological clinical changes of the patients. 
However, it needs further proofs by big-sample 
researches.  
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